Abstract

Abstract We studied the effect of ursodeoxycholic acid (UDCA) administration (15 mg/kg/day) on cholesterol absorption in 11 volunteers. Cholesterol absorption was estimated by feeding a standard dose of cholesterol, dissolved in butter, containing 5 μCi of [ 14 C]cholesterol and 10 μCi of [ 3 H]sitosterol (as a nonabsorbable marker). Feces were then collected for 5–6 days. Cholesterol absorption with β-sitosterol, corrected for losses not due to absorption, was estimated from the recovered radioactivity. After 20 days of treatment with UDCA, the study was repeated with each patient acting as his own control. Cholesterol saturation of bile and biliary bile acid composition were also studied before and after treatment. UDCA was virtually undetectable in bile before treatment, but became the most abundant bile acid (42.0 ± 17.2% of the total) after treatment. Although the molar percentage of cholesterol in bile fell in each patient after treatment, bile saturation critically depended on the criteria adopted to calculate the saturation index. Mean cholesterol absorption was 36.7 ± 9.3% of the administered dose in basal conditions and fell to 17.5 ± 11.3% (48% decrement) after treatment (P

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.